OMX Nordic 40
|
2 682,92
|
15,63
|
0,59 %
|
Analysen zu OMX Nordic 40-Werten
| 13:37 | AstraZeneca Overweight | Barclays Capital | |
| 13:36 | Novo Nordisk Equal Weight | Barclays Capital | |
| 11:14 | Nokia Overweight | Morgan Stanley | |
| 10:03 | Novo Nordisk Neutral | UBS AG | |
| 08:53 | ABB Market-Perform | Bernstein Research | |
| 07:56 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07:55 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.01.26 | Volvo AB Buy | UBS AG | |
| 14.01.26 | A.P. Moeller - Maersk A-S Sell | Goldman Sachs Group Inc. | |
| 13.01.26 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | ABB Sector Perform | RBC Capital Markets | |
| 13.01.26 | Volvo AB Outperform | RBC Capital Markets | |
| 13.01.26 | ABB Neutral | JP Morgan Chase & Co. | |
| 13.01.26 | Nokia Buy | Jefferies & Company Inc. | |
| 12.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.26 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 08.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Volvo AB Buy | Goldman Sachs Group Inc. | |
| 07.01.26 | Volvo AB Market-Perform | Bernstein Research | |
| 07.01.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 07.01.26 | AstraZeneca Overweight | Barclays Capital | |
| 06.01.26 | ABB Market-Perform | Bernstein Research | |
| 06.01.26 | ABB Underweight | Barclays Capital | |
| 06.01.26 | Hennes & Mauritz AB Underperform | Bernstein Research | |
| 06.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 05.01.26 | Ericsson Underperform | Bernstein Research | |
| 05.01.26 | Nokia Market-Perform | Bernstein Research | |
| 19.12.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 18.12.25 | ABB Hold | Jefferies & Company Inc. | |
| 17.12.25 | ABB Sector Perform | RBC Capital Markets | |
| 16.12.25 | Volvo AB Buy | UBS AG | |
| 16.12.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 12.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.12.25 | Hennes & Mauritz AB Underperform | Bernstein Research |